Botulinum Toxin Training for Neurological Diseases
October 18-19, 2011
Despite increasingly widespread use of botulinum toxins (BtX) for rehabilitation and neurological and other disorders, there is no recognized or regularly available training scheme in most European countries. Several UK and European guidelines recommend formal training, but available training is haphazard and depends heavily on drug industry input. This course was developed by MDS to address that gap. It was aimed at European clinicians or specialist nurses who wished to start or who are already using botulinum toxins and wished to improve their skills.
Day 1 covered the theory, with lectures from and discussion with international experts. Day 2 presented a morning of live case demonstrations in small highly interactive groups and a closing session. Topics included: diseases treated and the place of BtX in management; BtX biology; and practical strategies and techniques to deliver and monitor BtX treatments effectively in neurological conditions, especially movement disorders.
This course was approved for 10.0 CPD credit hours via the Royal College of Physicians.
At the conclusion of this activity, participants were able to accomplish the following:
- Discussed the biology of botulinum toxins and how they work in movement disorders
- Diagnosed and managed the relevant main neurological conditions overall, including the role of botulinum toxins
- Developed treatment plans including types of botulinum toxin to use, doses, adverse effects, adjuvant therapy, monitoring and long-term strategies
- Deployed injection techniques including use of EMG / stimulation and imaging for target localization
- Improved running of a botulinum toxin clinic
1. Medical practitioners in the relevant fields with a working knowledge of diagnosis and general management of the various conditions.
2. In some countries, specialist nurse practitioners or other paramedical equivalents with a working knowledge of diagnosis and general management of the various conditions appropriate to their grade
This course was supported by unrestricted medical education grants from the following:
Gold Sponsor Silver Sponsor
For more information contact the MDS International Secretariat at:
555 East Wells Street, Suite 1100
Milwaukee, Wisconsin 53202 USA
Email: email@example.com +1 414.276.2145; +1 414.276.3349, fax